Real-world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer: a methodological protocol to a study using five European databases

Aug-19

Cardiovascular Men's Health Oncology Pharmacoepidemiology Urology

AUTHORS : Dr Gincy George, King’s College London, Translational Oncology and Urology Research, London, SE1 9RT, UK – Email: gincy.e.george@kcl.ac.uk – Profile: https://www.kcl.ac.uk/people/gincy-george

JOURNAL : Fundamental & Clinical Pharmacology

REFERENCE: 33(4):479-499

DOI : 10.1111/fcp.12454

Read more

More publications

Apr-25

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Diabetes Pharmacoepidemiology

Read more

Feb-25

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study

Pharmacoepidemiology Rheumatology

Read more

Feb-25

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Pharmacoepidemiology Rheumatology

Read more